SOSV

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

CargoKite, founded in 2022 and based in Munich, Germany, develops autonomous cargo ships that use wind-powered propulsion through high-altitude kite systems paired with routing software to reduce fuel consumption and emissions, enabling flexible, sustainable maritime logistics with micro cargo ships.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Solano Energy is an asset-light power company focused on making renewable energy accessible. It aims to deliver affordable renewable electricity by building a network capable of supporting low upfront capital expenditure. The company develops equipment that automatically generates, stores, and distributes solar energy, leveraging artificial intelligence to optimize performance and energy use. Founded by engineers from Oxford and Cambridge, Solano Energy emphasizes technical innovation to simplify the adoption of solar power and reduce overall power costs for consumers.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

CargoKite, founded in 2022 and based in Munich, Germany, develops autonomous cargo ships that use wind-powered propulsion through high-altitude kite systems paired with routing software to reduce fuel consumption and emissions, enabling flexible, sustainable maritime logistics with micro cargo ships.

HausBots Limited, founded in 2017 and based in Birmingham, United Kingdom, specializes in designing and manufacturing wall-climbing robots for painting and decorating across various industries. Their flagship product, the V1 Wall Climbing Robot, is capable of navigating rough surfaces to perform tasks such as exterior and warehouse painting, high-definition visual inspections, and building and infrastructure surveys. The company's mission is to leverage technology to protect and maintain the built environment, enhancing productivity for clients by automating maintenance tasks at height.

SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security. Founded in 2013 and headquartered in Dublin, Ireland, the company employs a patented interactive platform that utilizes personal human interaction, registered biometric data, and unique virtual objects to create sophisticated digital signatures. This innovative approach replaces traditional passwords and PINs, significantly mitigating risks associated with identity theft and insider threats, particularly in critical sectors such as energy, transportation, communications, government, and defense. SensiPass’s products, including SensiAR and ImmersiveID, enable rapid authentication in various environments, including augmented and virtual reality. The company has received multiple accolades for its contributions to cybersecurity innovation, underscoring its commitment to providing robust identity assurance for users accessing both digital and physical assets.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

MotionsCloud provides an AI-powered computer vision platform that analyzes property and vehicle damage to automate insurance claims. Its engine automates damage detection and assessment, helping insurers streamline processing, reduce claim cycle times, and lower claims costs while improving customer experience. The solution supports integration with trusted services and aims to boost productivity. It has been shown to cut claim cycle times from 10 days to 3 hours and can save up to 75% on processing costs. MotionsCloud serves clients in the United States, Europe, and Southeast Asia.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.

Coffee Exchange operates a digital marketplace that aims to revolutionize the global coffee trading industry by promoting transparency and efficiency. The platform facilitates direct trade between coffee producers and roasters, eliminating intermediaries and enabling producers to earn significantly higher revenues. By providing real-time information and streamlining the entire green coffee trading process—from farm gate to consumer—Coffee Exchange enhances the supply chain while reducing costs for roasters. The company's services include coffee evaluation, logistics, customs clearance, quality inspections, and marketing support, ensuring a comprehensive solution for all participants in the trade. Currently, Coffee Exchange has over 1,100 coffee roasters in China engaged with select producers from countries such as Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. The platform is being trialed in the United States, with plans for expansion into the UK and South Korea.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Kyomei is a company based in Oxford, England, focused on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei employs innovative techniques in plant cell biology to scale the production of myoglobin, which enhances the flavor profile of meat alternatives by providing umami. This approach not only aims to improve the taste of plant-based products but also seeks to reduce reliance on carbon-intensive animal agriculture, promoting a more sustainable food system for consumers.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Nordetect is a Copenhagen-based analytical hardware company that develops lab-on-a-chip devices for environmental and agricultural analysis. Founded in 2016, it aims to bring medical-grade technology to the farming industry, enabling farm managers, agricultural service providers, and indoor growers to obtain reliable, easy-to-interpret data to improve harvests. The company’s nutrient analysis technology measures soil content of nitrogen, phosphorus, and potassium, providing results and data uploads, with recommendations on when to adjust agricultural techniques and allowing transparent tracking of soil nutrition.

Nordetect is a Copenhagen-based analytical hardware company that develops lab-on-a-chip devices for environmental and agricultural analysis. Founded in 2016, it aims to bring medical-grade technology to the farming industry, enabling farm managers, agricultural service providers, and indoor growers to obtain reliable, easy-to-interpret data to improve harvests. The company’s nutrient analysis technology measures soil content of nitrogen, phosphorus, and potassium, providing results and data uploads, with recommendations on when to adjust agricultural techniques and allowing transparent tracking of soil nutrition.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Mobio Interactive is a digital health company that develops tools for performance and health improvement in consumer and clinical populations. It offers an AI-powered digital theragnostic platform that delivers clinically validated psychotherapy programs personalized to each patient using digital biomarkers to quantify brain states without relying on wearables. Its mobile health stack enables private, remote delivery of therapy across multiple indications. The company also provides mindfulness applications Am Mindfulness, Wildflowers Mindfulness, and Actify Mindfulness that deliver medical-grade mindfulness training and objectively assess efficacy through mood, stress, and physiological signals captured by computer vision, such as heart rate, heart rate variability, breathing rate, and relative oxygen saturation. Founded in 2014, Mobio Interactive is headquartered in Toronto with offices in Zurich and Shanghai.

Nordetect is a Copenhagen-based analytical hardware company that develops lab-on-a-chip devices for environmental and agricultural analysis. Founded in 2016, it aims to bring medical-grade technology to the farming industry, enabling farm managers, agricultural service providers, and indoor growers to obtain reliable, easy-to-interpret data to improve harvests. The company’s nutrient analysis technology measures soil content of nitrogen, phosphorus, and potassium, providing results and data uploads, with recommendations on when to adjust agricultural techniques and allowing transparent tracking of soil nutrition.

Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Liberum was founded in September 2007 as an investment banking firm based in London, United Kingdom. It aimed to deliver a distinct approach to broking, prioritizing strong relationships with clients and fostering a supportive environment for its staff. The firm offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, chemicals, and real estate. Throughout its operation, Liberum focused on understanding client needs and encouraging staff development, which contributed to its growth and adaptability in a competitive industry. However, the firm is no longer active due to a merger and acquisition.

Liberum was founded in September 2007 as an investment banking firm based in London, United Kingdom. It aimed to deliver a distinct approach to broking, prioritizing strong relationships with clients and fostering a supportive environment for its staff. The firm offered a range of services, including capital raising, initial public offerings, mergers and acquisitions, corporate broking, and investment management, catering to various sectors such as aerospace, agriculture, chemicals, and real estate. Throughout its operation, Liberum focused on understanding client needs and encouraging staff development, which contributed to its growth and adaptability in a competitive industry. However, the firm is no longer active due to a merger and acquisition.

HausBots Limited, founded in 2017 and based in Birmingham, United Kingdom, specializes in designing and manufacturing wall-climbing robots for painting and decorating across various industries. Their flagship product, the V1 Wall Climbing Robot, is capable of navigating rough surfaces to perform tasks such as exterior and warehouse painting, high-definition visual inspections, and building and infrastructure surveys. The company's mission is to leverage technology to protect and maintain the built environment, enhancing productivity for clients by automating maintenance tasks at height.